1.
Huxley N, Baldessarini RJ: Disability and its treatment in bipolar disorder patients. Bipolar Disord 2007;9:183-196.
2.
Colom F, Vieta E, Sánchez-Moreno J, Goikolea JM, Popova E, Bonnin CM, Scott J: Psychoeducation for bipolar II disorder: an exploratory, 5-year outcome subanalysis. J Affect Disord 2009;112:30-35.
3.
Favre P, Baciu M, Pichat C, Bougerol T, Polosan M: fMRI evidence for abnormal resting-state functional connectivity in euthymic bipolar patients. J Affect Disord 2014;165:182-189.
4.
Townsend JD, Torrisi SJ, Lieberman MD, Sugar CA, Bookheimer SY, Altshuler LL: Frontal-amygdala connectivity alterations during emotion downregulation in bipolar I disorder. Biol Psychiatry 2013;73:127-135.
5.
Houenou J, Wessa M, Douaud G, Leboyer M, Chanraud S, Perrin M, Poupon C, Martinot JL, Paillere-Martinot ML: Increased white matter connectivity in euthymic bipolar patients: diffusion tensor tractography between the subgenual cingulate and the amygdalo-hippocampal complex. Mol Psychiatry 2007;12:1001-1010.
6.
Tang YY, Lu Q, Geng X, Stein EA, Yang Y, Posner MI: Short-term meditation induces white matter changes in the anterior cingulate. Proc Natl Acad Sci 2010;107:15649-15652.
7.
Scholz J, Klein MC, Behrens TEJ, Johansen-Berg H: Training induces changes in white-matter architecture. Nat Neurosci 2009;12:1370-1371.
8.
Takeuchi H, Sekiguchi A, Taki Y, Yokoyama S, Yomogida Y, Komuro N, Yamanouchi T, Suzuki S, Kawashima R: Training of working memory impacts structural connectivity. J Neurosci 2010;30:3297-3303.
9.
Favre P, Baciu M, Pichat C, De Pourtalès M-A, Fredembach B, Garçon S, Bougerol T, Polosan M: Modulation of fronto-limbic activity by the psychoeducation in euthymic bipolar patients. A functional MRI study. Psychiatry Res Neuroimaging 2013;214:285-295.
10.
Sarrazin S, Poupon C, Linke J, Wessa M, Phillips M, Delavest M, Versace A, Almeida J, Guevara P, Duclap D, Duchesnay E, Mangin J-F, Le Dual K, Daban C, Hamdani N, D'Albis M-A, Leboyer M, Houenou J: A multicenter tractography study of deep white matter tracts in bipolar I disorder: psychotic features and interhemispheric disconnectivity. JAMA Psychiatry 2014;71:388.
11.
Zatorre RJ, Fields RD, Johansen-Berg H: Plasticity in gray and white: neuroimaging changes in brain structure during learning. Nat Neurosci 2012;15:528-536.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the...
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.